$1.18 Billion is the total value of Novo Holdings A/S's 15 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VTI | VANGUARD INDEX FDStotal stk mkt | $319,508,000 | +1.2% | 2,979,100 | 0.0% | 27.18% | +6.4% | |
| OPHT | Sell | OPHTHOTECH CORP | $228,485,000 | -13.7% | 4,910,487 | -16.8% | 19.43% | -9.3% |
| VGK | VANGUARD INTL EQUITY INDEX Fftse europe etf | $113,916,000 | +3.5% | 2,101,000 | 0.0% | 9.69% | +8.8% | |
| INGN | INOGEN INC | $113,543,000 | +2.0% | 3,549,320 | 0.0% | 9.66% | +7.2% | |
| NVRO | NEVRO CORP | $105,199,000 | +23.9% | 2,194,841 | 0.0% | 8.95% | +30.3% | |
| ALDR | ALDER BIOPHARMACEUTICALS INC | $92,386,000 | -0.8% | 3,201,183 | 0.0% | 7.86% | +4.3% | |
| OTIC | OTONOMY INC | $76,909,000 | +6.1% | 2,175,025 | 0.0% | 6.54% | +11.5% | |
| FLXN | FLEXION THERAPEUTICS INC | $51,416,000 | +11.5% | 2,283,131 | 0.0% | 4.37% | +17.3% | |
| WMGIZ | WRIGHT MED GROUP INCright 03/01/2019 | $20,296,000 | -10.0% | 4,720,065 | 0.0% | 1.73% | -5.4% | |
| AKBA | AKEBIA THERAPEUTICS INC | $16,847,000 | -4.6% | 1,516,387 | 0.0% | 1.43% | +0.4% | |
| TKAI | Buy | TOKAI PHARMACEUTICALS INC | $13,381,000 | -23.0% | 1,184,196 | +0.4% | 1.14% | -19.1% |
| AERI | AERIE PHARMACEUTICALS INC | $13,152,000 | +7.4% | 419,652 | 0.0% | 1.12% | +12.9% | |
| TTPH | Sell | TETRAPHASE PHARMACEUTICALS INC | $8,479,000 | -85.5% | 231,419 | -84.3% | 0.72% | -84.8% |
| XENE | XENON PHARMACEUTICALS INC | $2,151,000 | -14.6% | 127,563 | 0.0% | 0.18% | -10.3% | |
| XENT | Sell | INTERSECT ENT INC | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD INDEX FDS | 41 | Q3 2022 | 64.7% |
| INOGEN INC | 34 | Q2 2022 | 68.8% |
| VANGUARD INTL EQUITY INDEX F | 29 | Q4 2016 | 37.6% |
| AMICUS THERAPEUTICS INC | 22 | Q3 2023 | 4.1% |
| AKEBIA THERAPEUTICS INC | 21 | Q3 2020 | 4.8% |
| VERONA PHARMA PLC | 21 | Q2 2022 | 1.9% |
| CORVUS PHARMACEUTICALS INC | 20 | Q4 2020 | 7.1% |
| INSPIRE MED SYS INC | 20 | Q3 2023 | 1.8% |
| CABLE ONE INC | 19 | Q3 2023 | 9.7% |
| FLEXION THERAPEUTICS INC | 19 | Q3 2021 | 4.7% |
View Novo Holdings A/S's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyteir Therapeutics, Inc. | August 03, 2023 | 1,547,136 | 4.4% |
| Disc Medicine, Inc. | June 28, 2023 | 1,090,772 | 4.8% |
| Galera Therapeutics, Inc. | June 28, 2023 | 2,100,000 | 4.9% |
| VectivBio Holding AGSold out | May 26, 2023 | 0 | 0.0% |
| LanzaTech Global, Inc. | February 17, 2023 | 15,814,845 | 8.1% |
| Bolt Biotherapeutics, Inc.Sold out | January 04, 2023 | 0 | 0.0% |
| Arcellx, Inc. | December 12, 2022 | 1,750,000 | 4.0% |
| MINERVA SURGICAL INC | November 03, 2022 | 1,322,473 | 4.5% |
| Milestone Pharmaceuticals Inc. | October 24, 2022 | 1,378,538 | 4.6% |
| Galecto, Inc. | September 30, 2022 | 2,497,791 | 9.8% |
View Novo Holdings A/S's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-03-28 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-20 |
| SC 13D/A | 2024-03-20 |
| 144 | 2024-03-18 |
| 4 | 2024-03-18 |
| SC 13D/A | 2024-03-18 |
| 144 | 2024-03-14 |
| SC 13D/A | 2024-03-07 |
View Novo Holdings A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.